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Abstract 
This research study aims to understand the medical decision-making process for new mothers 
who may be experiencing depression, anxiety, or psychological distress following birth, and 
understanding their treatment preferences. This study replicates one by Patel and Wisner (2011), 
and was developed from their suggestions in further research. The goal was to replicate the 
methodology with a more diverse sample of new mothers. The study reviews recent literature on 
postpartum depression and anxiety, including, symptoms, etiology, risk factors, the impact on 
family functioning and child development, as well as the literature on medical decision-making. 
The Decisional Conflict Scale, the Problem-Solving Decision Making Scale, and the Control 
Preferences Scale were used to assess the decision-making process, desired control in problem 
solving and decision making, and decisional conflict. The results revealed that women preferred 
more collaborative problem solving related to diagnosing, and preferred to retain more 
responsibility related to decision making about treatment. The group of mothers who had made a 
decision about treatment endorsed statistically lower levels of decisional conflict versus those 
who had not made a treatment decision. Furthermore, respondents who endorsed a diagnosis of 
depression, anxiety, or a mood disorder (self-reported) also endorsed statistically lower levels of 
decisional conflict. In reference to decision making and preferences, there was no difference 
found between groups of respondents who endorsed psychological distress and those who did 
not. Regardless of symptoms, respondents indicated they preferred collaborative  
decision-making and wanted to retain control in the process.  
Keywords: Postpartum Depression, Medical Decision Making, Treatment 
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Treatment Decision Making in the Postpartum Period:  
Examining Women’s Preferences and Perspectives  
 Postpartum depression and other perinatal psychiatric disorders are significant health 
issues for new mothers, families, and children. The prevalence of perinatal psychiatric disorders 
(PPD), including depression and anxiety, varies depending on the definition being used, but 
recent estimates indicate between 7%-20% of mothers in the United States will experience 
depression and/or anxiety in the perinatal or postpartum period (Mayberry, Horowitz, & Decler, 
2007; O’Hara & Wisner, 2014; Stuart & Koleva, 2014; Wisner et al., 2000). Despite extensive 
research on risk factors, onset, course, epistemology, and treatment options, there are many 
underserved women who still do not engage in treatment (McCarthy & McMahon, 2008). The 
dissemination of knowledge about PPD, while important, has not done enough to encourage 
mothers to seek professional services. More research is warranted to understand postpartum 
depression, what is involved in the medical decision-making process, and what factors prompt 
women to seek treatment (McCarthy & McMahon, 2008). Women seek invaluable support from 
family members, friends, community organizations, and services outside of the mental health 
profession; however, given the impact of PPD on family functioning, the mother’s mental health, 
and infant development, providers and clinicians must work to support women in the medical 
decision-making process. There are mental health and physical health consequences associated 
with untreated postpartum depression. As such, there is a need to understand the medical 
decision-making process for women who may be experiencing these symptoms (Horowitz, 
Damato, Duffy, & Solon, 2005; Sit & Wisner, 2005). With increased knowledge about this 
process during the postpartum period, medical providers will be better equipped to support new 
mothers.  
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 This study investigated the treatment decision-making process for women in the 
postpartum period, and was based on Patel and Wisner’s (2011) quantitative investigation of 
medical decision making. Patel and Wisner used the Control Preferences Scale, the Problem 
Solving Decision Making Scale, and the Decisional Conflict Scale to investigate the women’s 
decision-making process, women’s desired role in the decision, and their preferred treatment 
options (Patel, 2011; Patel & Wisner, 2011).  Patel and Wisner suggested replicating the 
methodology as the women in their study were predominantly white, upper or middle class, 
married, and college educated. Patel and Wisner noted that the homogenous sample was a 
limitation in the study, and this study hoped to address this issue. The current study looked to 
understand medical decision making with a wider variety of women to determine their desired 
roles in decision making, their treatment preferences, and the level of decisional conflict related 
to medical decision making in the postpartum period.  
 Treatment decision making has been an area of interest in the medical profession for 
many years. The literature shows that patients struggle to decide which medical options are best 
suited for them, and this can delay their participation in treatment. Women with postpartum 
depression experience this internal struggle and are unsure about which interventions are best for 
their situation (Sit & Wisner, 2005). There is an adjustment period following childbirth; stress 
levels increase and the ability to cope decreases as internal resources are strained. Cognitive 
flexibility and decision-making abilities are taxed in the midst of other changes, and it is 
important to understand this process to provide the best possible care (Sit & Wisner, 2005). 
There are various treatment modalities available including psychopharmacological interventions, 
psychotherapy, and increased social support, but many women have trouble weighing the options 
and ultimately making a choice (Leahy-Warren & McCarthy, 2007). Knowledge gained through 
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this quantitative investigation helps understand women’s perspectives and gives information 
about the level of decisional conflict. This information can help providers better understand and 
effectively support the decision-making process (Sit & Wisner, 2005). Given the various factors 
associated with medical decision making, this quantitative investigation focused mainly on a 
woman’s desired role in problem solving and decision making (e.g., active, passive, or 
collaborative), decisional conflict regarding treatment options, and the level of control they wish 
to have in making the final decision about their mental health treatment. The results indicate 
there are factors associated with decision making in the postpartum period which, if attended to, 
can help support women making the decision whether or not to seek treatment and which options 
may be their preferred treatment modality. 
Background 
 New mothers experience many changes following birth, including physical, 
psychological, and family changes. If a new mother develops symptoms of depression, or 
experiences significant psychological stress or anxiety, she may experience a decline in her 
internal coping resources. The increase in psychosocial stress related to their role change as they 
adjust to life as a parent can impact many areas of functioning (Horowitz et al., 2005). 
Furthermore, many women face stigma associated with depressed mood following childbirth and 
are reluctant to ask for help for fear of being judged by others (Dennis & Chung-Lee, 2006). 
Many women are reluctant to use medications for depression or other psychiatric disorders, 
particularly when pregnant and breastfeeding, due to the potential risks and impact on the infant. 
Research regarding the impact of antidepressants on fetal and infant development is mixed, but 
women are understandably concerned with the potential risks associated with this treatment 
option (Misri et al., 2013). Increased stress following childbirth and difficulty accessing support 
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can leave many women feeling reluctant to engage in treatment. The medical community has 
made strides to support new mothers, but there is still a need to help more women engage in 
treatment. Medical providers do their best to support women and their families, but they are 
often unsure how to make an appropriate referral if they uncover symptoms of depression or 
anxiety. Physicians’ time and resources are strained, and they are often uncomfortable 
diagnosing and treating psychiatric conditions. Although they may screen for symptoms, they do 
not always know the next step if the screen is positive for depression or anxiety (Pearlstein, 
2008). This study helps to understand the patient’s experience, and give information to providers 
with the hope they can better support the decision-making process. There are many factors that 
hamper the ability to seek and engage in treatment, but if providers have a better understanding 
of the factors involved in decision making, they can be more helpful to their patients and their 
families. For these reasons, it is important to educate the medical community on the factors that 
facilitate treatment decisions.   
Statement of the Problem 
 Medical decision making and the Patel and Wisner (2011) study. New mothers 
struggle with the decision to seek treatment and, once they do, which treatments are best for 
them. They may have information on postpartum and perinatal depression and anxiety, but the 
information alone may not be enough to help them make a decision. There are many variables 
involved in the decision-making process, such as feasibility and access to care, or the risks and 
benefits of the treatment, and the impact on the child (e.g., psychopharmacological interventions, 
perinatal risk, and neonatal risk, and breast feeding). The underlying issues that may prevent 
women from participating in treatment include accessibility to care, cost, and stigma associated 
with postpartum depression and anxiety. The medical community has investigated patients’ 
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desired roles in decision making for many conditions, but decision making related to 
psychological treatment is unique. For a patient with depression, there are other factors at play 
which may influence the decision-making process (Sit & Wisner, 2005).  While increased 
knowledge about the various treatments is critical, it is also important to understand how a 
woman views her role in making healthcare decisions (Wisner et al., 2000). While the medical 
literature provides information regarding decision making for other conditions, it is important to 
investigate these issues in the context of mental health treatment. 
 Patel and Wisner’s (2011) study revealed that women wanted (a) a collaborative 
relationship with their provider, wanted (b) shared decision making, and (c) opted for combined 
psychotherapeutic and psychopharmacological treatments. Their investigation revealed that, in 
general, women wanted a more active role in medical decision making; however, the study was 
conducted with a homogenous sample of women who were White, generally well-educated, and 
from a higher socioeconomic status. Women with limited social and economic resources may 
have different preferences in regards to decision making. For example, access to healthcare can 
have a significant impact on medical decision making as women with fewer resources may have 
more limited treatment options. Psychological inquiry and research should be representative of 
the population as a whole, and one goal of this study was to address the lack of diversity in the 
previous sample. The current study addressed some of the homogeneity problems, including 
socioeconomic diversity, but more research with racial and ethnic minorities, or other 
marginalized populations, would help providers greatly. There are various treatments available, 
but they are useless if they are underutilized. Therefore, it is important to understand how 
women approach this decision and how medical providers can use this information to support 
decision-making (Patel & Wisner, 2011). By doing so, providers can understand women’s 
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perspectives and desired role in making the decision, thus increasing the likelihood that they will 
seek treatment. 
 Diversity. Ross, Campbell, Dennis, and Blackmore (2006) examined demographic 
variables reported in various research studies on postpartum depression to determine if the 
current literature represents the majority of women. They discovered that approximately 50% of 
studies did not sufficiently report on or collect demographic data. It is difficult to discern where 
and to whom the results are applicable without this information. The literature that sufficiently 
reported and collected demographic variables revealed that the majority of the research was 
conducted with homogeneous samples of women 25-35 years-old, and who were partnered or 
married. Almost two-thirds of the research on PPD reviewed by Ross et al. had been with women 
from middle or high SES. Research has provided a wealth of knowledge on PPD, but it is 
important to recognize the limitations and expand the research to make it applicable to all 
women.  
 One goal of this study was to recruit as many women as possible from all backgrounds, 
but there is an inherent limitation given the region where the study was conducted. Participants 
who completed the surveys in this study are more varied in terms of their socioeconomic status 
and level of education as compared to the previous study (Patel & Wisner, 2011). Other studies 
have found that some risk factors for PPD are associated with low socioeconomic status, but this 
population is under represented in the literature. Limited economic and financial resources have 
been correlated with higher rates of PPD, and women with little social or emotional support are 
at greater risk for developing PPD. Marital status, as a part of social support, has also been 
correlated with higher rates of PPD (Segre, O’Hara, Arndt, & Stuart, 2007). While lower SES is 
not a direct predictor of PPD, there are higher rates of known risk factors found within this 
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population.  The current study did include more variability related to socioeconomic and 
education status compared to previous research. Given the limitations in the area where the study 
was conducted, the study sample was limited in terms of ethnic and racial diversity. The 
sampling procedures included reaching out through social media, contacting local online 
mother’s groups, and collaborating with others who work with new mothers in the region, and 
accessing participants through email distributions. The study addressed some, but not all, of the 
issues related to the homogeneity of the previous study. 
 Objectives of the current study. This study aimed to investigate the  
decision-making process for new mothers, some of whom may have experienced psychological 
distress or symptoms of depression or anxiety following birth. Patel and Wisner’ study (2011) 
revealed important factors related to women’s perspectives on decision making, but there were 
limitations inherent in the homogeneous sample. Their research reflects the trend in the literature 
to use homogenous samples and it is important to expand their findings. The study uncovered 
valuable information in regards to decision making and preferences, and the goal of this study is 
to use their methodology to understand if the conclusions are similar for a more diverse sample. 
This was met with some success as the participants in this study represent more of a variety than 
in the previous sample, although there is still a lack of ethnic and racial diversity. A review of the 
literature indicates that while much is known about PPD, many women are underrepresented in 
the research studies. Women who are at an increased risk for developing PPD must be included 
to gain a better understanding of their experience and how to help them seek treatment. It is 
important to determine if increased psychosocial stressors associated with lower SES, or other 
demographic variables, affect women’s decision-making process or treatment preferences. Given 
that many groups of women are underrepresented in the current literature (Ross et al., 2006; 
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Segre et al., 2007), this study sought to investigate if previous findings based on homogenous 
samples can be applied to a more diverse population. 
 Research questions and hypotheses based on previous research. This study is a 
quantitative exploration of women’s perspectives on making the decision to seek treatment and 
sought to help understand: (a) women’s treatment preferences, (b) decisional conflict, and (c) the 
role women want to play in regards to treatment decisions. Through a better understanding of the 
decision-making process, doctors and clinicians can provide better recommendations for 
treatment and help women get the support they need.  This study looked to answer the following 
research questions which stem from Patel and Wisner’s (2011) study: (a) What are women’s 
treatment preferences for PPD?; (b) What is the level of decisional conflict for these new 
mothers?; and (c) What role do women want in making the treatment decision (p. 590). 
Women’s treatment preferences may be different given their education level, marital status, SES, 
or geographic location. The objective was to gain a more complete understanding of women’s 
perspectives on this topic. 
 Previous research indicated women prefer the collaborative decision-making process, but 
wish to defer problem solving activities (e.g., diagnosis) to their provider. This is the general 
trend in the medical literature, as well as the research specifically exploring postpartum 
depression (Patel & Wisner, 2011). However, there is variability in regards to some decision-
making processes when accounting for socio-demographic variables. Patel and Bakken (2010) 
researched medical decision making with an ethnic minority population. Their study revealed 
that, while clients still preferred shared decision making for treatment, they had a more passive 
decision-making style. Furthermore, Levinson, Kao, Kuby, and Thisted (2005) revealed a similar 
trend in medical decision making. They investigated three aspects of decision making: options, 
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knowledge, and the decision. Their study revealed that knowledge and the decision varied 
depending on socio-demographic variables, but found no differences in regards to options for 
treatment. It appears that everyone prefers to be offered choices by their doctor. However, they 
found that individuals with higher education status preferred more active participation in 
decision making. They confirmed the finding that women preferred an active role in decision 
making, and also the finding that Hispanic and African American participants deferred more to 
the physician for knowledge and final decision making (Levinson, Kao, Kuby, & Thisted, 2005). 
Given the variability, one goal of this study will be to clarify, and hopefully support, earlier 
research.  
 In response to treatment preferences, it was hypothesized that women in this study would 
prefer the combined treatment options, utilizing both medication and psychotherapy for the 
treatment of postpartum depression. It was hypothesized that women would prefer an active role 
in decision making; specifically, they will defer problem solving (e.g., generating a diagnosis) to 
their provider, but will prefer a collaborative or active role in deciding which treatment as 
measured by the Problem Solving Decision Making Scale (Deber, Kraetschmer, & Irvine, 1996; 
Patel & Wisner, 2011). Their results indicated that women did prefer an active role in treatment 
decision making but also preferred that there is collaboration in determining a diagnosis as well. 
Patel and Wisner (2011) assessed for decisional conflict which can delay decision making. While 
decisional conflict was present for many participants in their study, it did not reach levels 
associated with delayed decision making. Therefore, it was hypothesized that decisional conflict 
would be present for many women in the current study, but impact on decision making may vary. 
This investigation aimed to uncover treatment preferences and it was hypothesized that: (a) 
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participants will prefer the combined treatment option, (b) women would prefer collaborative 
decision making, and (c) decisional conflict may be present for most women. 
Literature Review 
 The phenomenon of postpartum and perinatal depression, anxiety, and other mood 
disorders, and how they are defined, diagnosed, and conceptualized continues to be debated. This 
was reflected in the changes to the DSM-5 regarding depression and anxiety, and other 
psychiatric conditions with peripartum onset (APA, 2013; Sharma & Mazmanian, 2014).  
Diagnostically, there is not a distinct category for postpartum depression or anxiety. It is a 
diagnostic specifier in the DSM-5 which states that symptom onset has occurred between 4 
weeks and 6 months after childbirth (e.g., with peripartum onset). This specifier can be used with 
psychiatric disorders including depressive disorder, bipolar and related disorders, and brief 
psychotic disorders (APA, 2013). One positive change in the DSM-5 is that it was acknowledged 
that symptoms can emerge during pregnancy which may result in closer monitoring, detection, 
and early intervention (O’Hara & Wisner, 2014; Sharma & Maziman, 2013). While the changes 
in the DSM-5 were a step in the right direction, many advocates and researchers in the field have 
proposed the changes were not substantial enough (O’Hara & Wisner, 2014; Sharma & 
Maziman, 2013). The specifier cannot be used with anxiety or obsessive-compulsive and related 
disorders which many women experience in the peripartum and postpartum periods (Sharma & 
Maziman, 2013). Furthermore, many women experience symptom onset outside of the proposed 
timeline. Most research indicates symptoms can emerge anytime in the postpartum period (up to 
the first year). There is also concern that the DSM-5 changes do not accurately describe the 
diverse experience for women, especially related to anxiety and obsessive-compulsive disorders, 
and the changes do not fully reflect current state of the research on perinatal psychiatric disorders 
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(O’Hara & Wisner, 2014; Sharma & Maziman, 2013). Hopefully future changes to the diagnostic 
criteria will include more substantial information on perinatal psychiatric conditions. 
 It must be noted that the current study was designed, and the survey was disseminated to 
participants, when the DSM-IV was still in use. There was one item on the survey where 
respondents were asked if they had been diagnosed with a mood disorder, depression, or anxiety 
(Patel, 2011; Patel & Wisner, 2011).  This item is simplified and may not reflect the myriad of 
psychiatric disorders and conditions outlined in DSM-5. Lastly, it is a self-reported diagnosis, 
and it is likely that respondents had been given the diagnoses using DSM-IV criteria.  
 Postpartum depression is a wide spread women’s health issue. Women from various 
cultures, ethnicities, and geographic locations are diagnosed with PPD and other psychiatric 
conditions during pregnancy and after childbirth, and the symptoms affect multiple domains of 
functioning (Leahy-Warren & McCarthy, 2007). Infant related stressors are unique to the 
experience of postpartum depression and anxiety. For example, symptoms of anxiety may be 
present but the worries, thoughts, or rumination may be geared toward the health and safety of 
the infant. The negative thoughts about the self associated with depression may be related to 
thoughts of being a “bad parent” or “inadequate parent.”  In the context of postpartum 
depression, the themes and content of these cognitions can be geared toward childrearing or 
parenting (Albright, 1993). Women are often reluctant to seek treatment and disclose that they 
are struggling for fear of being judged for these thoughts and feelings. It is important to 
understand risk factors for PPD, the impact on infant development, and have an understanding 
women’s experience. These three areas are reviewed here to support the rationale for this study.  
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 Overview and risk factors. Depression, anxiety, and other psychiatric conditions in the 
peripartum and postpartum period vary in their presentation, severity, and duration. The felt 
experience is unique for each individual, but the severity can range from what is coined 
“postpartum blues” to the more severe “postpartum psychosis” (Flynn, 2005). Postpartum 
psychosis is very rare (approximately 1-2 per 1,000 births), but there is a higher risk for 
infanticide (Albright, 1993; Flynn, 2005). Not every women will experience the same symptoms 
or will have those symptoms impact their lives in the same way. The symptoms commonly 
associated with peripartum psychiatric disorders include mood swings, irritability, anxiety, 
anger, and depression. These symptoms impact may areas of a mother’s life, including her 
family, her relationship with her child, and how she lives and cares for herself day-to-day. There 
is a great need to research and understand this phenomenon as this experience impact not only 
the mother, but the child as well (O’Hara, 2009). Beyond discrete symptoms, women experience 
psychosocial impairment in multiple domains of functioning. A new mother experiencing 
symptoms of depression and anxiety may isolate or may withdraw from supportive relationships 
(Albright, 1993). The symptoms impact functioning and can range in severity and duration, 
depending on the client and their unique circumstances.  
 The risk factors associated with PPD include having a pre-existing mood disorder, 
inadequate social support, life stressors, child stressors, and a non-supportive spousal 
relationship (Flynn, 2005). Through understanding these factors, physicians, clinicians, and new 
mothers can become more aware of the potential for symptoms to develop. A pre-existing mood 
disorder or family history of mental illness appears to be the number one risk factor for 
developing PPD. Inadequate social support and life stressors are risk factors for any mood 
disorder, and are not specific to PPD (Flynn, 2005). However, two risk factors that are unique to 
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PPD include child stressors and a non-supportive spousal relationship. These factors can also 
influence the medical decision-making process as mothers may not feel they have adequate 
social support around making the choice to seek treatment. Infant stressors, the change in the 
family system, increased responsibility, and decreased sleep associated with childrearing may 
make a mother vulnerable to developing PPD (Flynn, 2005). Knowledge of these risk factors is 
important and many clinicians discuss these with their patients. However, disseminating this 
information does not guarantee accurate diagnosing or engaging in treatment (Flynn, 2005). 
Understanding the risk factors is one of the first steps in assessing for the disorder, and it is 
important to know the risk factors to help mothers understand their experience and perhaps 
engage in treatment. If a mother feels supported and comfortable discussing risk factors with her 
healthcare providers, and the possibility that symptoms may emerge, she may be more likely to 
reach out for support. 
 Depression and mood deregulation during pregnancy are considered risk factors for the 
development of PPD, with a pre-existing mood disorder being the most strongly correlated factor 
(Albright, 1993; Horowitz et al., 2005). Additionally, lack of social support and familial support 
are risk factors as well. A strong social network can buffer the effects of postpartum depression 
and anxiety, as women perceive emotional, physical, and childcare support from those around 
her. Decreased social support and lower marital satisfaction were found to be correlated with 
symptoms of depression in one study, while women with strong social supports experienced 
more self-efficacy and confidence in their new role (Albright, 1993).  
 Clinicians and doctors should assess risk factors when symptoms are present to 
accurately diagnosis and plan for treatment. This can be particularly true for a mother who has 
experienced depression, or other psychiatric conditions, in the past. Early intervention for PPD 
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can help alleviate symptoms and increase psychosocial functioning. Factors such as social and 
marital support, life stress, and pre-existing mood disorders are among those most strongly 
correlated with the onset of PPD. Although demographic variables such as age, socioeconomic 
status, or educational status have not been deemed risks factors for PPD, they do indicate the 
presence of life-stressors which can contribute to PPD (Albright, 1993; Horowitz et al., 2005).  
Screening for risk factors can help new mothers and their providers begin the dialogue about 
PPD in hopes that treatment can be provided. The availability of resources, whether social or 
economic, has been implicated in the onset of PPD as these factors are related to stress levels. 
When the resources are available, women can more readily cope with their role change and the 
adjustment associated with child-rearing (Flynn, 2005, Horowitz et al., 2005).  
 Impact on infant development. Postpartum and peripartum depression and mood 
fluctuations significantly affect the mother, child, and her family. Symptoms of depression and 
anxiety can impact parenting behaviors, and a mother may experience increased preoccupation 
with the infant or intrusive thoughts about the child (APA, 2013). The changes in childrearing 
behaviors affect infants’ emotional, physical, and cognitive development (Flynn, 2005). If a 
mother is experiencing severe symptoms, the parent-child relationship can be affected, there may 
be attachment disruptions, or symptoms can influence the bonding between the mother and child. 
Symptoms may change a mother’s attunement, and mutual regulation affects infant development. 
Emotional and behavioral development happens in the context of the parent-child relationship, 
and can be influenced by a parent’s emotional responsiveness (Flynn, 2005). A parent 
experiencing symptoms of depression may feel overwhelmed and be slower to respond to the 
child’s needs. They have more trouble thinking flexibly, and may experience irritability in their 
interactions with the infant (Flynn, 2005). If the caregiver withdraws physically and emotionally, 
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cognitive and physical development of the infant may be impacted (Paris, Bolton, & Weinberg, 
2009). Maternal anxiety and depression in the prenatal and postpartum periods have been 
associated with low birth weight, labor complications, and affects the overall health of the baby 
(Flynn, 2005; Wenzel, 2011). Given what is known about the effects on infant development and 
health, women’s emotional health, and family functioning, it is important to understand how to 
help women engage in efficacious treatment. 
 There are many women who suffer from anxiety based disorders during the peripartum 
and postpartum period. Women experiencing severe symptoms of anxiety may be hypervigilant, 
experience extreme fear or nervousness, or feel helpless, which may impact their parenting 
behaviors. A mother experiencing high anxiety may have less confidence in her role as mother 
and doubt her parenting choices, which affect the maternal experience (Wenzel, 2011). 
Symptoms of anxiety including stress, worry, and rumination, can impact a mother’s ability to 
adjust to her new role. Additionally, the physiological changes associated with anxiety can affect 
fetal development, which will impact behavioral and emotional development in children. 
Whether through biological mechanisms or psychological changes, anxiety, stress, and mood 
dysregulation affects child development and the mother-infant dyad (Wenzel, 2011). These 
symptoms can have a significant impact on the health and wellbeing of the mother, and can in 
turn, influence the parent-child relationship.  
 A mother with PPD is adjusting to her new role while simultaneously managing 
symptoms of depression, and she may find it more difficult to meet her child’s needs. There are 
feelings of sadness, tearfulness, and guilt associated with depression that can lead to emotional 
and physical withdrawal (Jacob et al., 2010; Leahy-Warren & McCarthy, 2007). A new mother 
experiencing symptoms may begin to judge herself as a parent or worry extensively over the 
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safety of the baby, which may impact her parenting behaviors. Research has indicated that 
depressed caregivers may struggle to respond in a warm, empathic manner to the child, and they 
may communicate less with their children (Middleton, Scott, & Renk, 2009). Furthermore, 
depression can affect cognitive perceptions, especially towards the infant, and they may begin to 
perceive their children as more difficult (Albright, 1993; West & Newman, 2003). There are 
significant consequences if PPD goes untreated.  It is difficult to determine causality between 
these variables, and the negative interaction cycles should be considered in their totality when 
discussing the effects of depression on child development. For example, studies may have 
correlated parental depression with negative behaviors in children, but many studies use self 
reports where the parent may be negatively appraising their child as a result of cognitive 
perceptions (Cummings & Davies, 1999). In essence, it is important to understand the impact of 
depression on family functioning, but difficult to discern causality between the variables.    
 This experience has implications for infant development, familial functioning, and the 
health of the mother (Albright, 1993; Battle & Zlotnick, 2005; Flynn, 2005). Taking on the role 
of parent is a significant life change, and some mothers judge themselves harshly, especially if 
experiencing symptoms of psychological distress. This can lead to a decreased sense of self 
efficacy and confidence in parenting skills, which can exacerbate symptoms of depression and 
anxiety (Horowitz et al., 2005). For these reasons, it is not only the mental health of the mother, 
but also the needs of the child that are affected by PPD. It is imperative to find meaningful ways 
to support women, reduce stigma associated with peripartum and postpartum depression and 
anxiety, and work to improve the health and wellness of mothers and their children. Women’s 
experience of PPD can be devastating and, if untreated, can have long standing effects on the 
health and wellbeing of both the child and the mother (Leahy-Warren & McCarthy, 2007). A 
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child’s emotional development and the mother-infant attachment can be affected, which in turn 
impacts child development (Jacob et al., 2010). This study investigated treatment decision 
making as a way to buffer against these effects of PPD through helping women seek support. It is 
important to understand the complexity of PPD and gain insight into what variables may lead to 
more successful outcomes for children and their families. As such, the current study sought to 
uncover women’s perspectives on seeking treatment to mitigate these effects.  
 Impact on medical decision-making. Medical decision making is a complicated process 
that involves more than simply educating a client or patient about their options for treatment. 
Treatment options for managing PPD have been proven effective but many women are still 
underserved. Treatment options include individual and/or group psychotherapy, other 
psychosocial interventions such as support groups, and medication interventions, particularly 
antidepressants. Many women continue to be reluctant to engage in treatment, despite education 
from their provider on their options (McCarthy & McMahon, 2008). Research has indicated that 
there are many factors that promote help-seeking behaviors, which creates a more complex 
picture of the decision-making process. These factors include healthcare providers and their 
competency, knowledge of PPD, family and social support, previous experience with mental 
health professionals, pre-existing mental health issues or mood disorders, beliefs about mental 
illness, and treatment options. Furthermore, new mothers face stigma and are concerned with the 
impact of various treatments on the heath of the baby (e.g., psychopharmacological medication 
while breastfeeding). The literature surrounding the use of medications in pregnancy varies 
depending on the type of medication being used. However, mothers are concerned with the 
impact the medications may have on fetal and infant development. Many women opt not to 
participate in this form of treatment due to the risk factors (Misri et al., 2013). Reviewing the 
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risks and benefits associated with treatment impacts their decision-making process and will 
impact a mother’s decision to seek treatment (Flynn, 2005; Sit & Wisner, 2005).  
 Postpartum depression will affect multiple areas of functioning but, for the purposes of 
this study, its impact on decision making is highlighted here. PPD includes symptoms of 
irritability, sadness, hopelessness, lethargy, sleep disturbances, suicidal behavior, as well as 
problems with concentration, guilt, and worthlessness (Flynn, 2005).  Many new mothers 
experience high levels of anxiety and panic symptoms as well (Albright, 1993). These symptoms 
affect not only family functioning, quality of life, and infant development, but also women’s 
problem solving and decision-making capabilities (Sit & Wisner, 2005). Many women do seek 
help, but symptoms interfere with their ability to advocate for their needs, seek social support, or 
effectively ask others for help. It is particularly important for healthcare providers to engage in 
the assisted decision-making process for helping mothers seek treatment. Through getting a 
better perspective on the decision-making process while experiencing possible psychological 
distress, clinicians and practitioners can help mothers streamline the options for treatment (Sit & 
Wisner, 2005). For these reasons, the onus falls on the provider to understand the process and 
factors associated with decision making. This study compared the decision making styles of 
women who endorsed psychological stress, depression, or indicated a mood disorder, with those 
who denied these symptoms. This information helps to understand if the decision-making 
process, treatment preferences, or decisional conflict is different for women experiencing 
symptoms compared to those who have not.  
 Patients prefer different roles in the decision-making process depending on the healthcare 
decision being made, the information available, and the relationship they have with their 
provider. In general, past research has indicated that patients prefer providers to perform the 
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problem solving tasks associated with diagnosing and identifying appropriate treatment. 
However, collaborative decision making increases self-efficacy, control, and responsibility for 
one’s own care which can be valuable to a client’s confidence (Deber et al., 1996; Sit & Wisner; 
2005; Wisner et al., 2000). As discussed in the results section, findings from the current study 
showed that this sample of women preferred collaboration on diagnosing as well, with little 
deferment to relying solely on the doctor’s direction. Furthermore, decisional conflict influences 
an individual’s ability to make a decision. Patel & Wisner (2011) revealed that while women’s 
decisional conflict was elevated, it was not high enough to interfere with their ability to make a 
decision. Other research has indicated that individuals with depression experience significant 
decisional conflict, which often thwarts the ability to make decisions (van Randenborgh, de 
Jong-Meyer & Hüffmeier, 2010). These factors have been uncovered in different patient 
populations and will be addressed in the context of the current study.  
 The “risk-benefit” model of treatment decision making focuses on the variables involved 
in identifying treatment modalities and, ultimately, making a decision (Wisner et al., 2000). The 
providers must be aware of the risks of untreated depression, as well as those associated with 
various treatments. For example, Wisner et al. examined the risk and benefits of treating 
depression during pregnancy. They identified several modalities that are similar to treatments 
available for PPD including psychotherapy, somatic therapy such as ECT and light therapy, and 
psychopharmacological interventions. However, each of these modalities has risks associated 
with them that must be weighed against the benefits before making a decision. The mother is not 
only considering the risks and benefits for herself, but also her child, and in this way examining 
PPD is different than other medical conditions. We must also consider that the decision to not 
seek treatment is valid in this context as well (Wisner et al., 2000). The treatment of PPD 
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becomes more complicated as it is not just the health of the mother, but also the child, that must 
be considered. Examining risks and benefits is not as straightforward as it seems. The risks 
associated with each modality are barriers to treatment for women. The risks associated with 
psychopharmacological interventions for a mother who is breast feeding may prohibit her from 
seeking this type of treatment. The literature on antidepressants and breastfeeding suggests that 
specific types of medications are less harmful than others, while literature on anxiolytic 
medications suggests that these have significantly adverse effects on infants. A mother must 
decide whether or not to engage in such interventions, and this varies depending on the 
symptoms, severity, and how they interact with daily functioning (Pearlstein, 2008). There are 
risks associated with any type of intervention, and these often delay or prevent a woman from 
gaining access to care. While psychotherapy may seem like a good alternative for breastfeeding 
mothers, there are still barriers to engaging in this type of treatment. The time constraints, cost, 
and stigma associated with psychotherapy may outweigh the benefit of engaging in this type of 
treatment. Through examining how women weigh the risks and benefits, we can help support 
individual women in the decision-making process. The risk-benefit model of decision making 
demonstrates the complexity of this treatment decision, and thus the need to understand the 
process addressed by this study. 
 It is also important to consider how psychological distress and depression may affect 
decision-making and cognitive processes. One study by Wisner et al. (2000) demonstrated that 
while mild and moderate levels of depression may not interfere with decision-making 
capabilities, severe depression can affect the capacity to make a choice. There is the chance that 
a patient’s decision-making has been impacted in such circumstances, thus affecting their ability 
to appreciate the information being presented. A patient must be able to understand the situation, 
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options, consequences and outcomes associated with treatments, and make a choice. According 
to Wisner et al. severe depression can compromise these capabilities and delay decision making. 
Providers must be aware of the interaction between symptoms of depression and the ability to 
make a decision about treatment (Wisner et al., 2000). Through understanding the  
decision-making process thoroughly, a provider is more equipped to identify these circumstances 
and take the appropriate steps to ensure a patient is making an informed treatment choice. This 
study addressed the issue by comparing scores on the decision-making measures between the 
group of mothers who endorsed symptoms to those who did not to explore if there was a 
differences in preferences or decision-making characteristics. 
Research Hypotheses 
 Information from the current study will help providers understand the medical  
decision-making process, and this is necessary given the number of mothers who actually engage 
in treatment.  New mothers with PPD experience stress associated with increased responsibility 
and a decrease in emotional regulation skills, leaving them without the resources to manage their 
new role effectively. Participating in treatment for PPD can help them to be present as a mother, 
meet the needs of their infant, and engage in self-care (Sit & Wisner, 2005). There are multiple 
avenues for treatment including therapy and pharmacological interventions, but each has risks 
and benefits for new mothers (McCarthy & McMahon, 2008). This study explored treatment 
preferences, decisional conflict, and the problem-solving decision-making processes; it was 
hypothesized that, regardless of socioeconomic variables, women would: 
 Prefer combined treatment options, including psychopharmacological and therapeutic 
interventions. 
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 Prefer a collaborative decision-making process with their provider when choosing their 
treatment, but defer problem solving (e.g., diagnosis) to their doctor. 
 Would experience some level of decisional conflict in the postpartum period, which may 
or may not impact their decision-making process. 
Furthermore, it was hypothesized that: 
 There will be no difference between the decision-making process for women who have 
followed through with treatment, compared to others who have not. 
 Data will be collected from participants who have both endorsed and denied symptoms of 
psychological stress. It is hypothesized that there will be a higher level of decisional 
conflict for those participants who have endorsed symptoms of psychological stress. 
However, it is posited that other areas of decision making and treatment preferences will 
remain the same, regardless of symptoms. 
The study included surveys and quantitative statistical analyses to determine if socio-
demographic variables are associated with preferences and decision-making styles. These 
hypotheses will be explored through the questionnaire and proposed analytic strategies. 
Methodology 
 The study is a quantitative investigation using a self-report survey aimed at examining 
medical decision making related to treatment for postpartum depression (Patel, 2011; Patel & 
Wisner, 2011). The three surveys distributed have been validated and their psychometric 
properties and are well established (Deber et al., 1996; Degner, Sloan, & Venkatesh, 1997; 
O’Conner, 1995). Patel and Wisner’s 2011 study is outlined here to demonstrate the structure of 
the study. Patel and Wisner utilized the Ottawa Decision Support Framework (ODSF) and 
investigated decision-making conflict, problem solving, and treatment preferences. The ODSF is 
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a conceptual framework that is used to guide individuals through making health-related 
decisions. It is widely used for patients experiencing decisional conflict in relation to health 
decisions. The ODSF includes a needs assessment and supported decision-making, as well as 
investigating outcomes of the decisions made with providers (Patel & Wisner, 2011). A patient’s 
first decision is whether or not to participate in treatment, and then move to examining the 
treatment options. Patients make these decisions with input from their medical providers and 
other educational resources, such as handouts or information from the internet. Some want to 
make these medical decisions independently, with family, or in collaboration with their 
providers. Others want a less active role and decide based on the provider’s recommendations. 
This study examined decisional conflict, desired role in decision making, and treatment 
preferences to truly aid women in making these decisions. The study used Patel and Wisner’s 
version of the 2011 survey along with more demographic questions about income level and 
sexual orientation (Patel, 2011; Patel & Wisner, 2011). The survey included the Decisional 
Conflict Scale, Control Preferences Scale, and the Problem Solving Decision Making Scale 
along with demographic questions (Patel, 2011; Patel & Wisner, 2011). 
Measuring Decisional Conflict, Problem Solving, and Desired Control  
 Decisional conflict plays an important role in the process and this uncertainty can delay 
decision making as individuals struggle internally, reflecting on their values, and externally as 
they sift through the available information (O’Connor, 1995). The medical community has 
sought to reduce decisional conflict by educating patients and using decision aids. It is important 
to understand decisional conflict in regards to PPD because women are already using internal 
coping resources to manage their symptoms and their new role as a mother. There are factors that 
contribute to decisional conflict such as “…skills deficit in making or implementing decisions, 
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emotional distress, and perceived pressure from important others who are imposing their views” 
(O’Connor, 1995, p. 26). These are issues that women with PPD may already be struggling with, 
and thus understanding their decisional conflict becomes more important in helping them make 
decisions (Patel & Wisner, 2011).  
 Women’s role in decision making is examined to help providers understand their place in 
the process. Deber, Kraetschmer, and Irvine (1996) developed the widely used Problem-Solving 
Decision Making Scale to determine patient’s desire role in both tasks related to this process. 
Problem solving includes determining diagnoses, understanding risks and benefits, and 
identifying treatment options; decision making involves actually selecting the treatment. Problem 
solving and decision making are not mutually exclusive and cannot be separated easily, but it is 
important to examine both. Many patients wish to share decision making, but defer problem 
solving to the professionals because they rely on their expertise. This was found in Patel and 
Wisner’s (2011) study; most women wanted to defer problem solving to the provider while 
sharing the decision making. Importantly, very few women wanted to solely keep the 
responsibility of problem solving, indicating that they do value the input of the provider but 
some wanted to make the decision more independently. Women valued their autonomy in 
decision making while prizing the information provided by the professionals (Patel & Wisner, 
2011). This information can help providers understand their role in the process. It was 
hypothesized that the results reflect the trend towards collaborative or independent decision 
making.  
 Lastly, the Control Preferences Scale helps to uncover the role women want. It 
determines whether or not an individual prefers an active, passive, or collaborative role with their 
provider. The results in Patel and Wisner’s (2011) study further indicated that women desired a 
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collaborative decision-making process. This knowledge is important to providers, but the 
collaborative role may be less desirable to different subset of women. The objective of this study 
was to determine if these themes are present when the variability of the sample is increased, 
which will help providers better serve their clients. 
 Patel and Wisner (2011) hoped that clinicians could understand what options to offer if 
they understood the decision-making process, including the decision to not seek treatment. The 
study revealed that the participants preferred collaborative decision making with direct contact 
with a medical professional. The study also revealed that they preferred combined treatment 
options, with both counseling and medication management. The high SES and educational status 
of the sample may have influenced variables that guided decision making. The sample in this 
study was more diverse as related to education status and SES. This study explored whether or 
not these demographic variables had an impact on treatment preferences, level of decisional 
conflict, or the desired role in decision-making. 
Sample Description 
 Respondents were recruited using online mother’s support groups and email distributions. 
A web based survey was distributed to participants (Patel, 2011; Patel & Wisner, 2011). Women 
who were over 18 years old with an infant between 0-36 months were included in the analyses; 
four surveys were excluded as the child was too far outside the age range resulting in a total of 
31 participants. It should be noted some of the participants were still within the postpartum and 
perinatal timeframe, while other participants were answering these questions about their 
decision-making preferences while outside of this time period. No exclusions were made on the 
basis of race, ethnicity, sexual orientation, marital status, educational status, occupation, age, or 
income level. Participants did need to be able to read and write in English (Liberto, 2011). They 
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completed an internet survey which included: (a) the Decisional Conflict Scale, (b) Problem 
Solving Decision Making Scale, and (c) the Control Preferences Scale (Patel, 2011; Patel & 
Wisner, 2011).  
 Demographic information collected included: age, relationship status, yearly income, 
occupation, education level, race, ethnicity, and sexual orientation. The survey included 
questions asking if the participant has been diagnosed with postpartum depression or had 
experienced psychological stress, anxiety, or sadness, following birth. One item on the survey 
inquired about the participant’s treatment preference, thus addressing the first research question 
(Patel, 2011; Patel & Wisner, 2011). No identifying information was collected and all responses 
were confidential.  
The Decisional Conflict Scale 
 The Decisional Conflict Scale can reveal uncertainty about medical decisions, which can 
ultimately delay decision-making (O’Connor, 1995). This measure was included to answer the 
following question: What is the level of decisional conflict for these new mothers?  The scale has 
been used to aid in decision making for medical or health related decisions. It has been found 
valid and reliable to understand a person’s decisional conflict in relation to healthcare. The DCS 
contains scales related to uncertainty about the decision, effective decision-making, and factors 
contributing to uncertainty (O’Connor, 1995). The DCS assesses how women feel about the level 
of information they have regarding their options (O’Conner, 2005). It is a 16-item measure with 
a Likert scale ranging from 0-4 for each item. The internal consistency of the DCS ranges from 
0.78 to 0.92 and the test-retest coefficient was reported to be 0.81. The scores on the DCS can 
range from 0 to 100 (e.g., no conflict to high conflict). Scores above 37.5 indicate high 
uncertainty about the decision, and are associated with delayed decision making (O’Connor, 
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1993; Patel & Wisner, 2011). Scores lower than 25 are associated with making a decision and 
indicate low decisional conflict (O’Connor, 1993; Patel & Wisner, 2011). The scale can 
discriminate between those women who have low decisional conflict, and are prepared to make a 
choice and those with high conflict who may delay their decision making. The items correlated 
with particular constructs such as knowledge informing the decision, regret towards choice, and 
discontinuing treatment following a decision (O’Connor, 1993). 
The Problem-Solving Decision Making Scale  
 The Problem-Solving Decision Making Scale is a second validated measure aimed at 
assessing problem solving and decision making variables, including the amount of information 
desired and the level of involvement in the decision. This measure was included to determine 
how active women would like to be in the decision-making process, and who should have the 
most control in the problem-solving process. Information from this scale will address the 
following research question: what role do women want in making the treatment decision?  The 
measure assesses for how active, or passive, women would like to be in regards to problems 
solving tasks such as determining diagnosis, treatment options, and examining risks and benefits 
related to treatment.  It will uncover their desired role in the actual decision making as well, and 
who will make the ultimate decision (e.g., the practitioner, the patient, or collaborative approach; 
Deber et al., 1996). The PSDM scale includes 6 items, each scored on a 0-5 Likert scale. The 
first 4 items are aimed at assessing the participants’ problem solving regarding treatment, and the 
last 2 items are geared to medical decision making (Deber et al., 1996). The respondents are 
given a medical scenario and are asked to indicate “…who should determine/decide” (Patel & 
Wisner, 2011, p. 591) based on a 5-point Likert scale. The vignette or medical scenario for this 
particular study will be: “You are pregnant or have already given birth and you have been feeling 
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sad and down lately. You decide to visit your doctor about this” (Patel & Wisner, 2011, p. 591). 
They would then choose from the following items: “(1) Doctor alone; (2) Mostly the doctor; (3) 
Both equally; (4) Mostly me; (5) Me alone” (Patel & Wisner, 2011, p. 591). The reliability of the 
PSDM scale and subscales are as follows: full scale shown to be Chronbach’s alpha= .71- .90, 
problem solving only Chronbach’s alpha shown to be .79-.90, and decision making only 
Chronbach’s alpha shown to be .67-.93 (Patel & Wisner, 2011). The mean scores are calculated 
for each task involved in problem solving and each task in decision making. Scores less than 3 
indicate that the women want to defer responsibility to the doctor, scores ranging from 3 to 3.99 
indicate shared problem solving and decision making, and scores over 4 indicate that the patient 
wishes to problem solve and decide independently (Patel & Wisner, 2011). 
The Control Preferences Scale 
 The Control Preferences Scale is a measure designed to assess preference for the amount 
of control in decision making for medical treatment. Given the variety of treatments available to 
consumers, the scale was developed to understand the patient’s preference for control in medical 
decision making. This scale will also address the research question regarding the role women 
prefer in making the treatment decision through understanding the level of control they want in 
the process. The CPS has been used in medical research for decades, and has been demonstrated 
as a reliable and valid measure of this construct (Degner et al., 1997). As the CPS developed 
from grounded theory, criterion validity was established through defining the construct and using 
unfolding analysis to establish validity. Reliability has been demonstrated through repeated 
studies with cancer patients (Degner et al., 1997). The CPS is a 5-item scale whereby participants 
choose the statement that most closely relates to their preferred role in decision making. The 
responses can indicate an active, passive, or collaborative role in decision making with their 
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provider (Patel & Wisner, 2011). There has been some investigation into how patients’ 
preference for control varies depending on demographic characteristics such as age, gender, or 
type of medical issue (e.g., cancer; Singh et al., 2010). This is important for the purposes of this 
study as women’s preferences may vary depending on their symptoms, age, marital status, or 
other variables. The CPS can uncover the amount of control they wish to have in the decision. 
Data Analyses 
 Data reported includes means and standard deviations to relay information about 
responses on each measure, as well as other descriptive statistics regarding demographics, 
socioeconomic status, and race/ethnicity. These analyses determined treatment preferences, the 
average level of decisional conflict, amount of desired control, and the level of involvement 
mothers would like related to problem solving and decision making. Two-tailed T-tests were 
used to determine if there were clinically significant differences in decision-making 
characteristics between groups of participants who endorsed psychological stress and anxiety, 
and those who had not (Patel & Wisner, 2011; Robson, 2002). T-tests were used to determine if 
there were differences in decision-making processes for groups of women who reported they had 
been diagnosed with a mood disorder following birth versus those who had not. T-tests were also 
used to compare the mothers who had made a treatment decision to those who had not to 
determine if there were significant differences related to (a) their level decisional conflict, (b) 
their desired control in decision making, and (c) tasks related to problem solving and decision 
making. T-tests were also performed to determine if there were differences related to mothers 
who had household incomes above $65,000 to those below $65,000 related to their  
decision-making processes. T-tests were performed to determine if there were differences 
between mothers who had attained a college degree and those who had not, and their scores on 
TREATMENT DECISION MAKING IN THE POSTPARTUM PERIOD 31  
 
the treatment decision-making measures. Analyses also included t-tests to determine if there 
were differences in decisional conflict levels for women who had made a decision regarding 
treatment and those who had not yet made a decision. Finally, analyses also included comparing 
average problem solving scores to average decision-making scores to determine if there was a 
clinically significant difference in the level of control women desired when examining problem 
solving and decision making separately. 
Results 
 The results of the study presented here includes a description of sample and general 
demographic information, including age, race, marital status, parental status (e.g., age of child), 
educational level, and income level. The analyses of each measure administered will be 
described, including results from the Control Preferences Scale, the Problem Solving Decision 
Making Scale, and the Decisional Conflict Scale. The analyses will address the research 
questions, and including: (a) What are women’s treatment preferences for symptoms of 
depression or anxiety during the postpartum period? (b) What is the level of decisional conflict 
for these new mothers? and (c) What role do women want in making the treatment decision?  
Further analyses were conducted to determine if the presence of psychological stress or 
depression or income level affected the scores on each measure and are described for each 
individual measure.  
Demographic Information 
 The survey was distributed to women in New Hampshire through social media, email 
distribution, and in collaboration with women’s groups such as La Leche League and local 
chapters for mother’s online support groups, resulting in a total of 35 surveys obtained. Four 
surveys were not included in the statistical analyses due to the child being too far outside the age 
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range resulting in a total of 31 respondents (N= 31.)  Respondents ranged from age 20 years old 
to 42 years old. The post-partum periods ranged from 6 weeks to 3 years-old. All surveys with a 
child under 3 years old were included in the analyses. Demographic information collected 
included age, marital status, employment status, race, ethnicity, sexual orientation, and yearly 
family income. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT DECISION MAKING IN THE POSTPARTUM PERIOD 33  
 
Table 1.  
Martial Status (N=31) 
Marital Status Number % 
Married 26 80.08 
Living with Parter 5 16.12 
Single 0 0 
Divorced 0 0 
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Table 2.  
Age (N=31) 
Age Range Number % 
20-25 3 9.68 
26-30 12 38.71 
31-35 10 32.26 
36-40 4 12.90 
41-45 1 3.1 
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Table 3.  
Education Status (N=31) 
Highest Grade Level Achieved Number % 
High School Diploma 4 12.90 
Trade/Technical Certificate or 
Diploma 
3 9.68 
Some College 2 6.45 
College Degree 11 35.48 
Graduate School 11 35.48 
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Table 4.  
Race and Ethnicity (N=31) 
 Number % 
Hispanic 2 6.45 
Non-Hispanic 29 93.55 
White 29 93.55 
Black 1 3.23 
Asian/Pacific Islander 1 3.23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT DECISION MAKING IN THE POSTPARTUM PERIOD 37  
 
Table 5.  
Sexual Orientation (N=31) 
 Number % 
Gay/Lesbian 0 0 
Bisexual 1 3.23 
Transsexual 0 0 
Heterosexual 29 93.55 
Asexual 1 3.23 
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Table 6.  
Employment Status (N=31) 
 Number % 
Employed 22 70.97 
Military 0 0 
Student 0 0 
Homemaker 9 20.03 
Out of work and looking for 
work 
0 0 
Out of work and not looking 
for work 
0 0 
Retired 0 0 
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Table 7.  
Household Yearly Income (N=31) 
Income range Number % 
Below $10,000 0 0 
$10,000-$25,000 0 0 
$25,000-$35,000 2 6.67 
$35,000-$45,000 3 10 
$45,000-$60,000 5 16.67 
$60,000-$75,000 1 3.33 
$75,000-$100,000 6 20 
$100,000-$150,000 11 36.67 
$150,000 + 2 6.67 
 
 Participants were asked a series of questions aimed at assessing for the presence of 
psychological stress following childbirth, as well as a diagnosis of a mood disorder. Participants 
were also asked if they had actually made a decision regarding participating in treatment (Patel, 
2011; Patel & Wisner, 2011). Respondents were asked to indicate if they had experienced 
sadness or depression following birth; 51.61% of participants endorsed they had symptoms of 
sadness. In reference to psychological stress and anxiety, 61.29% indicated they had these 
symptoms. While postpartum mood disorders affect 7%-20% of mothers in the United States 
(Mayberry et al., 2007; O’Hara & Wisner, 2014; Stuart & Koleva, 2014; Wisner et al., 2000), 
29.03% of new mothers in this sample indicated they had been diagnosed with a mood disorder 
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following birth. In response to the question about making a treatment decision, 54.84% indicated 
they had made a decision regarding treatment. 
Research Questions and Hypotheses 
 Preferred treatment options and treatment preferences. The first research questions 
aimed to uncover which treatment options new mothers preferred for managing mood or stress in 
the postpartum period. It was hypothesized that women would prefer combined treatment options 
including both medication and therapy, based on previous research (Patel & Wisner, 2011). 
Respondents were asked to select their preferred method of treatment from five possible choices 
including medication only, therapy only, combination of medication and therapy, no treatment, 
or unsure. The option for no treatment was important as some women may not opt to proceed 
with treatment for managing stress, anxiety, or sadness. Results indicated 29.03% preferred 
combined treatment options, 29.03% preferred therapy only, 6.45% preferred medication only, 
12.9% opted for no treatment, and 19.35% indicated they were unsure about their preference. 
64.51% of the respondents selected some form of treatment option while only 12.9% opted for 
no treatment, while 19.35% of respondents were still undecided. The majority of participants 
indicated a preference for some type of intervention. Women were more likely to choose to 
participate in treatment versus opting for no treatment. Women in this sample indicated therapy 
only and combined treatment options were most preferred, and medication only was the least 
preferred treatment option. Results from this study indicated more women preferred no treatment 
over the medication only treatment option. It should be noted this is reflective of the participant’s 
preference and may not be the treatment they actually participated in. Overall, most women 
selected some treatment option and intervention with the majority selecting a combination of 
medication and therapy. 
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 Decisional conflict. The second research question asked about the level of decisional 
conflict for new mothers contemplating this treatment decision. Decisional conflict has been 
associated with delays in decision making in regards to healthcare decisions. High decisional 
conflict may impact the decision-making process and delay participation in treatment (O’Conner, 
2005). It was hypothesized there may be some level of decisional conflict involved with this 
process. The Decisional Conflict Scale (DCS) looks to uncover any uncertainty in making a 
decision which can delay the decision-making process (O’Conner, 2005). Two-tailed T-tests 
were performed to determine if the group of women who made a decision (versus those who had 
not) had different levels of decisional conflict.  T-tests were also performed to determine if there 
were differences in decisional conflict between (a) the group of mothers who endorsed 
psychological stress compared to those who did not, (b) the group of mothers who endorsed 
sadness compared to those who had not, and (c) the group of mothers who reported a diagnosis 
of a mood disorder versus those who had not. Responses on the DCS can range from low 
decisional conflict to high decisional conflict, and respondents with high decisional conflict often 
delay the decision making (O’Conner, 2005). Overall, 51.16% of respondents had a low 
decisional conflict score, 29.03% revealed a high decisional conflict score, and 19.35% achieved 
a moderate score. The total average score indicated relatively low decisional conflict in this 
sample of new mothers (Mean= 26.84; SD= 22.04).  
 Notably, there was a statistically significant difference in the level of decisional conflict 
between the group of women who had made a decision compared those who had not (see Table 
8). Women who had yet to make a decision had significantly higher levels of decisional conflict 
scores (Mean= 41.51; SD= 19.43) than women who had made a decision regarding treatment 
(Mean= 14.71, SD=16.05). Those who had yet to make a decision had an average score in the 
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high-conflict range, which is associated with delayed decision making (O’Conner, 2005). 
Statistically significant differences were also found between the respondents who endorsed a 
mood disorder versus those who had not. The respondents who endorsed a diagnosis had lower 
decisional conflict scores than those respondents who did not (see Table 8). 
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Table 8. 
Results of Two-Tailed T-test Comparing Average scores on the Decisional Conflict Scale 
  Groups 
 Variable                           Endorsed Yes                     Endorsed No 
 Mean  SD Mean  SD N df T Sig 
         
Anxiety/Stress 
 
27.80 
 
25.08 
 
25.33 
 
17.07 
 
31 29 0.33 
 
ns 
Sadness/Depression 
 
20.41 
 
23.64 
 
33.70 
 
18.56 
 
31 28 -1.75 
 
ns 
Mood Disorder Diagnosis 
 
15.45 
 
15.73 
 
31.50 
 
22.83 
 
31 22 -2.25 
 
*0.035 
 
Made Decision Regarding 
Treatment 
14.71 
 
16.05 
 
41.57 
 
19.43 
 
31 25 -4.14 
 
*.0003 
 
Note.* p <.05 
Groups of respondents endorsed the presence or absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
 
 Results from the analyses did reveal significantly higher DCS scores for those 
respondents who had yet to make a decision regarding treatment. This addresses the research 
question about whether or not the presence of decisional conflict would impact the decision-
making process and results from these analyses indicate higher decisional conflict may be 
associated with a delay in decision making. New mothers who experience moderate to high 
levels of decisional conflict may delay decision making regarding treatment for depression or 
anxiety. Furthermore, analyses revealed statistically significant differences in decisional conflict 
for women who had made a decision as compared to the overall average, and a statistically 
significant higher DCS score for those had not made a decision when compared to the overall 
average.  
 Results from two-tailed and one-tailed t-tests did not reveal any statistically significant 
differences in decisional conflict scores between the group who endorsed psychological stress, 
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anxiety, or depression and those who did not. No difference was found related to income level or 
education status. Results could indicate the decision-making process is similar regardless of the 
presence of psychological stress, or these results could be because of the small sample size in 
this study. It would be important to investigate this area in future studies with more respondents 
to support these findings. 
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Table 9.  
Household Yearly Income Level and Decisional Conflict 
 Mean SD N Df T Sig 
Respondents Endorsed < $60, 000 24.45 17.20 10 25 -0.50 ns 
Respondents Endorsed > $60, 000 28.36 24.88 20    
 
Note.* p <.05 
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Table 10.  
Education Status and Decisional Conflict 
 Mean SD N Df T Sig 
Respondents without a college degree 37.85 26.51 9 11 -1.60 ns 
Respondents with a college degree 22.34 18.79 22    
 
Note.* p <.05 
      
 
 The Decisional Conflict Scale has subscales associated with various aspects of decision 
making and included: the informed subscale, values clarity subscale, support subscale, 
uncertainty subscale, and effective decision subscale (O’Connor, 1993). Two-tailed t-test were 
used to determine if there was a difference between groups of women who endorsed 
psychological symptoms and those who did not, and their scores on each subscale, as well as 
between the groups of women who had made a decision regarding treatment. Statistically 
significant results were found on the “informed” subscale which assessed a women’s perception 
of how much information she has regarding her decision. Women who had a self-reported 
diagnosis reported low scores which meant they felt they had more information, knew more 
about the benefits, and knew about the risks and side effects. Furthermore, women who had 
made a decision regarding treatment also had statistically significant lower scores indicating they 
felt more informed (see Table 11). Results from the “values clarity” subscale also revealed 
statistically significant results in that women who self-endorsed a diagnosis had lower scores 
indicating greater clarity around their values about the decision. Similarly, those who endorsed 
symptoms of sadness or depression had statistically significant lower scores on values clarity. 
Finally, those women who had made a decision about their treatment also showed statistically 
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significant lower scores, indicating they were clearer about what they valued and what mattered 
to them about this decision (see Table 12; O’Connor, 1993). The scores on the “support” 
subscale revealed one statistically significant result related to women who had made the 
decision. They endorsed lower scores indicating the perceived enough social support and advice 
regarding their decision (see Table 13; O’Connor, 1993). In the area of “uncertainty” there was a 
statistically significant different found between the group of women who had made the treatment 
decision and they showed scores reflective of a higher degree of certainty regarding their 
decision (see Table 14; O’Connor, 1993). Lastly, a similar result was found on the “effective 
decision” subscale which reflects satisfaction with the decision and participants feeling like they 
made an informed choice. Women who had made a decision had scores reflective of higher 
levels of effective decision making (see Table 15; O’Connor, 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT DECISION MAKING IN THE POSTPARTUM PERIOD 48  
 
Table 11.  
Results of Two-tailed T-test Comparing Average scores on the Decisional Conflict Scale: 
Informed Subscale 
 Groups 
 Variable                       Endorsed Yes             Endorsed No 
 Mean  SD N Mean  SD N df T Sig 
          
Anxiety/Stress 
 
29.82 
 
32.07 19 34.03 22.88 12 28 -0.43 ns 
Sadness/Depression 
 
21.35 26.52 16 39.44 29.46 15 28 -1.79 
 
ns 
Mood Disorder 
Diagnosis 
 
12.04 13.25 9 38.64 29.61 22 29 -3.45 *0.00086 
 
Made Decision 
Regarding Treatment 
13.24 17.69 17 53.57 23.05 14 25 -5.37 *1.62^-05 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
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Table 12.  
Results of Two-Tailed T-test Comparing Average scores on the Decisional Conflict Scale: Values 
Clarity Subscale 
 Groups 
 Variable                       Endorsed Yes             Endorsed No 
 Mean  SD N Mean  SD N df T Sig 
          
Anxiety/Stress 
 
23.25 27.72 19 27.78 19.25 12 29 -0.54 ns 
Sadness/Depression 
 
13.54 21.27 16 39.44 37.22 15 29 -3.03 *0.0052 
Mood Disorder 
Diagnosis 
 
8.33 12.5 9 31.82 25.15 22 28 -3.46 *0.0012 
 
Made Decision 
Regarding Treatment 
9.31 13.14 17 42.26 22.04 14 20 -4.92 *8.26^-05 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
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Table 13.  
Results of Two-Tailed T-test Comparing Average scores on the Decisional Conflict Scale: 
Support Subscale 
 Groups 
 Variable                       Endorsed Yes             Endorsed No 
 Mean  SD N Mean  SD N df T Sig 
          
Anxiety/Stress 
 
25.44 21.95 19 27.78 19.29 12 26 0.71 ns 
Sadness/Depression 
 
19.27 22.71 16 27.78 18.28 15 28 -1.15 ns 
Mood Disorder 
Diagnosis 
 
18.52 20.74 9 25.38 20.97 22 15 -0.83 ns 
Made Decision 
Regarding 
Treatment 
16.18 19.2 17 32.14 19.84274 14 27 -2.26 *0.032 
 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
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Table 14.  
Results of Two-Tailed T-test Comparing Average scores on the Decisional Conflict Scale: 
Uncertainty Subscale  
 Groups 
 Variable                       Endorsed Yes             Endorsed No 
 Mean  SD N Mean  SD N df T Sig 
          
Anxiety/Stress 
 
32.90 28.26 19 27.79 18.58 12 29 0.61 ns 
Sadness/Depression 
 
28.65 28.70 16 33.33 20.41 15 27 -0.53 ns 
Mood Disorder 
Diagnosis 
 
23.15 25.95 9 34.09 22.86 22 14 -1.09 ns 
Made Decision 
Regarding 
Treatment 
20.10 21.86 17 44.05 22.03 14 28 -3.02 *0.00531 
 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
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Table 15.  
Results of Two-Tailed T-test Comparing Average scores on the Decisional Conflict Scale: 
Effective Decision Subscale  
 Groups 
 Variable                       Endorsed Yes             Endorsed No 
 Mean  SD N Mean  SD N df T Sig 
          
Anxiety/Stress 
 
26.97 27.33 19 21.88 19.67 12 28 0.60 Ns 
Sadness/Depression 
 
19.53 27.85 16 30.83 19.40 15 27 -1.32 Ns 
Mood Disorder 
Diagnosis 
 
15.28 19.29 9 28.98 25.56 22 20 -1.63 Ns 
Made Decision 
Regarding 
Treatment 
13.60 17.01 17 38.84 25.38 14 22 -3.18 *0.0043 
 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
 
 Role in decision making. The third research question posited, “What role do women 
want in making this treatment decision?”  This question was addressed by two measures, the 
Control Preferences Scale (CPS) and the Problem Solving Decision Making Scale (PSDM). The 
role in the decision-making process may be active, collaborative or passive as measured by the 
CPS. Patients make healthcare decisions in collaboration with medical providers, but the level of 
responsibility changes depending on the healthcare decision and the patients’ personal preference 
related to their role in the process (Degner et al., 1997). The results from the PSDM helped 
answer this research question by investigating who should be responsible for certain tasks 
involved in making healthcare choices. Individuals vary in how much responsibility they wish to 
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retain and defer in reference to problem solving (e.g., diagnosing, determining treatment options) 
and decision making (Deber et al., 1996). Results from these two measures aid in understanding 
the desired role and level of control new mothers desire in making a decision to seek treatment. 
Two-tailed T-tests were performed to determine if there were differences in desired control (CPS 
scores and PSDM scores) for (a) the group of mothers who endorsed psychological stress 
compared to those who did not, (b) the group of mothers who endorsed sadness compared to 
those who had not, and (c) group of mothers who reported a diagnosis of a mood disorder versus 
those who had not.  
 The Control Preferences Scale. The Control Preferences Scale (CPS) was used to 
determine how much control respondents would prefer in the decision-making process for 
treatment (Degner et al., 1997). Question responses indicated whether respondents wanted retain 
control of decision making (active), share control with the medical provider (active shared), 
share control equally (collaborative), have the doctor make the decision with input from the 
consumer (passive shared), or confer control the medical provider (passive). None of the 
respondents selected to defer decision-making responsibilities to providers. All women sampled 
preferred to retain or share control related to this healthcare decision, rather than defer to the 
professional. Results revealed women indicated they wanted to retain decision making and 
consider input from their doctor (Mean= 2.23, SD= .67).  
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Table 16. 
Overall Distribution of Preferred Role Measured by the Control Preferences Scale 
Preferred Role % 
Active 12.90 
Active Shared 51.61 
Collaborative 35.48 
Passive Shared 0 
Passive 0 
 
 Two-tailed and one-tailed t-tests were performed to determine if the presence of stress 
and anxiety, depression, or a mood disorder impacted the level of desired control as measured by 
the CPS. The analyses were performed to determine if there was a statistically significant 
difference between the average CPS scores for women who endorsed psychological stress or 
anxiety, sadness or depression, or stated they had been diagnosed with a mood disorder, and 
those who had not. Additionally, a two-tailed t-test was performed to determine if there was a 
statistically significant difference on the CPS scores for women who had made a decision 
regarding treatment versus those who had not. Results from theses analysis did not reach 
statistical significance indicating there were no differences in the mean scores on the CPS for 
women who endorsed psychological stress or sadness, or indicated the presence of a mood 
disorder. These results may be impacted by the small sample size with low statistical power; 
however, in this sample, the presence of psychological stress did not impact the scores on the 
CPS indicating level of control women preferred related to this healthcare decision. Furthermore, 
no statistical difference was found between the average scores on the CPS for the mother’s 
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whose household income was above or below $60,000; the results on the CPS did not vary by 
income level. Finally, there were no differences found related to education status. 
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Table 17.  
Results of Two-Tailed T-test Comparing Average scores on the Control Preferences Scale 
between groups of respondents 
   Groups 
 Variable                                Endorsed Yes                     Endorsed No 
 Mean  SD Mean  SD N df T Sig 
         
Anxiety/Stress 
 
2.29 
 
0.66 
 
2.1 
 
0.74 
 
31 16 0.68 
 
ns 
Sadness/Depression 
 
2.13 
 
0.72 
 
2.33 
 
0.62 
 
31 29 -0.86 
 
ns 
Mood Disorder Diagnosis 
 
2.33 .50 2.18 
 
0.73 
 
31 22 0.66 
 
ns 
Made Decision Regarding 
Treatment 
2.24 
 
0.75 
 
 
2.21 
 
0.58 
 
31 29 0.09 
 
ns 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
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Table 18.  
Household Yearly Income Level and Control Preferences Scale Score 
 Mean SD N Df T Sig 
Respondents Endorsed < $60, 000 2.3 0.48 10 26 0.44 Ns 
Respondents Endorsed > $60, 000 2.2 0.77 20    
 
Note.* p <.05 
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Table 19.  
Education Status and Control Preferences Scale 
 Mean SD N Df T Sig 
Respondents without a college degree 2.44 0.53 9 20 -1.33 Ns 
Respondents with a college degree 2.14 0.71 22    
 
Note.* p <.05 
 
      
 
 The Problem-Solving Decision Making Scale. The Problem Solving Decision Making 
Scale (PSDM scale) is aimed at uncovering variables involved in problem solving and decision 
making. Questions assess how active participants would like to be in the decision-making 
process, as well as the level of desired control on different tasks related to decision making 
(Deber et al., 1996). Results on this measure are used to determine if women would like an 
active, collaborative, or more passive role in the decision-making process. Respondents are 
asked their preference for the level of input they, and their doctor, have related to diagnosing a 
condition, determining what treatment options are available, determining risks and benefits, and 
the likelihood they will occur, and the acceptability of these risks and benefits (Deber et al., 
1996). Analyses on this measure included two-tailed t-tests to determine if there was a 
significant difference on average scores between groups of women who indicated psychological 
stress and the presence of a mood disorder. 
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Table. 20  
Overall results and distribution on the Problem Solving Decision Making Scale N(%) 
Person Responsible                                               Task Responsibility 
 Diagnosis Determine 
treatment 
options 
Determine 
risks and 
benefits 
Determine 
likelihood 
of risks and 
benefits 
Determine 
acceptability 
of Risks and 
Benefits 
Make 
Decision 
Doctor 
Alone 3 (9.67) 2 (6.45) 3 (9.67) 5 (16.13) 1 (3.23) 1 (3.23) 
Mostly the 
Doctor 7 (22.58) 12 (38.71) 10 (32.26) 14 (45.16) 0 1 (3.23) 
Both 
Equally 15 (48.39) 13 (41.94) 15 (48.39) 12 (38.71) 13 (41.94) 10 (32.26) 
Mostly Me 6 (19.35) 4 (12.9) 3 (9.67) 0 13 (41.94) 11 (35.48) 
Me Alone 0 0 0 0 4 (12.9) 8 (25.81) 
 
 Two-tailed and one-tailed t-tests were performed to determine if the presence of stress 
and anxiety, depression, or a mood disorder impacted problem solving and decision-making 
tasks. No statistical difference was found between the groups of women who endorsed 
psychological stress or sadness, and their selection on PSDM items. Psychological stress, 
anxiety, or depression did not appear to influence the problem-solving/decision making scores on 
the PSDM in this sample. There was no difference in the scores between those who endorsed 
psychological stress or depression, and those who did not on the PSDM. Overall, average 
responses from this sample of women wanted to retain decision-making responsibility and share 
problem solving responsibility with their healthcare provider.  
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Table 21. 
Results of Two-Tailed T-test Comparing Average scores on the Problem Solving Decision 
Making Scale  
               Groups 
 Variable                                        Endorsed Yes                     Endorsed No 
 Mean  SD Mean  SD N df T Sig 
         
Anxiety/Stress 
 
2.84 .60 3.06 .46 27 20 -1.02 ns 
Sadness/Depression 
 
2.87 .53 3.10 .42 27 23 -1.23 ns 
Mood Disorder Diagnosis 
 
2.87 .67 2.94 .51 27 13 -.25 ns 
Made Decision Regarding 
Treatment 
3.01 .58 2.76 .50 27 24 1.26 ns 
 
Note.* p <.05 
Groups of respondents endorsed the presence of absence of the variables, as well as whether or 
not they had made a decision regarding treatment. 
 
 The overall average indicated women preferred collaboration related to problem solving 
and decision making (Mean= 2.93, SD= .54). However, when responses on the problem solving 
items and decision making items were analyzed separately, the average scores varied 
significantly. In the area of diagnosing, respondents indicated that they preferred collaborative 
decision making with their healthcare provider (Mean=2.52, SD=.57). In the area of actual 
decision making, respondents indicated they wanted to retain more control in the process 
(Mean=3.69, SD=.74). The results of a two-tailed T test revealed average scores on the decision-
making tasks were significantly higher than those on the problem solving tasks (see Table 22).  
Furthermore, the analyses revealed a statistically significant difference between the average 
decision-making scores and the overall PSDM average, as well as between the average problem 
solving score and the overall PSDM average. Women desired shared responsibility or 
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collaborative process in problem solving related to mental health diagnosis and treatment but 
preferred to retain responsibility related to making the actual decision.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT DECISION MAKING IN THE POSTPARTUM PERIOD 62  
 
 
Discussion 
 Medical decision making has been an area of interest for the medical community to 
determine how involved patients would like to be in regards to making healthcare decisions. 
Patients appear to prefer collaborative processes where there is shared responsibility between 
patient and provider when it comes to making healthcare decisions. Patients are informed 
consumers and while most value input from their medical provider, it appears there is some 
desired level of control when making a healthcare choice. Women who have recently given birth 
are often faced with making a healthcare decision about whether or not to seek treatment for 
psychological stress, anxiety, or depression. Women in the postpartum period are faced with 
multiple stressors as they transition into motherhood and many experience signs and symptoms 
of depression or anxiety. The current research study investigated how new mothers approach this 
healthcare decision and sought to understand different characteristics of decision making 
including level of control, decisional conflict, and preferences. The strengths and limitations of 
the study will be outlined, as well as suggestions for further research.  
 
Table 22. 
Results of Two-Tailed T-test Comparing Problem Solving Scores to Decision-making Scores  
                                 Tasks 
Problem Solving                     Decision Making 
Mean  SD Mean  SD N Df T Sig 
2.52 .57 3.69 .74 31 56 -6.88 *5.34^-09 
 
Note.* p <.05 
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Strengths and Limitations of the Study 
 Strengths. The current study involved a quantitative investigation of the  
decision-making process utilizing measures that have been shown to be valid and reliable tools 
for understanding healthcare decisions. The measures selected examined the level of desired 
control as well as examining the level of decisional conflict for new mothers. The Control 
Preferences Scale has been shown to be valid and reliable, particularly with cancer patients, but 
has also been used for understanding a variety of healthcare decisions (Degner et al., 1997). The 
Problem-Solving Decision Making Scale is another valid and reliable tool used to understand 
different tasks in making healthcare decisions (Deber et al., 1996). Finally, the Decisional 
Conflict Scale has been used widely in the medical community to understand how decisional 
conflict can delay and impact medical decisions, which ultimately can affect prognosis 
(O’Connor, 1995). The use of reliable and valid measures widely used in the medical community 
is one strength of the current study, as the results can be determined to reflect medical decision-
making processes. The current study also uses quantitative measures meaning its methodology 
can be replicated with different populations or at different times to determine if trends change 
(Patel, 2011; Patel & Wisner, 2011). Women’s preference and decision-making styles may 
change as more research or awareness of postpartum mood disorders is made available. 
Furthermore, the study can be replicated with other subsets of parents, such as teenage mothers 
or single parents, to determine if the findings are applicable to these families. 
 Limitations and areas for further research. Psychological research and recruiting 
participants is challenging. The participants in this study were recruited through social media, 
local women’s support groups, and in collaboration with community providers working with new 
mothers. Unfortunately, distribution and recruitments yielded only 35 responses and the small 
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sample size is a significant limitation of this study. The statistical analyses did not detect 
significant differences between subsets of respondents but this could be a result of the small 
sample size. It is difficult to conclude with certainty that no difference exists between the groups 
based on this study.   However, although the sample was small, the trends detected were similar 
to previous research studies in reference to treatment preference and desired role in the process. 
Although some analyses may have not yielded significant results, some results and conclusions 
can be drawn from examining the overall average scores, trends, and demographic information.  
  One goal of the current study was to address the lack of diversity in psychological 
research, specifically in the area of postpartum depression. There was more socioeconomic 
diversity in this sample, but unfortunately there was little ethnic and racial diversity in this study. 
The sample was also homogenous in terms of marital status and sexual orientation. While there 
was some greater diversity in educational status and socioeconomic status in the current study, it 
would be beneficial to include a wider variety of new mothers in future research. Other areas of 
research could be related to single mothers, teenage mothers, or mothers living below the poverty 
like. There is always a need to expand psychological research findings and although this study 
addressed one part of the diversity concern, more research is warranted to increase 
generalizability of the findings. 
 There were some limits to the study in that not enough data was collected to answer some 
of the research questions or address certain hypotheses. For example, it could not be determined 
if there was a difference between groups of participants who completed treatment versus those 
who had not, and their decision-making process. Further research could address this question to 
determine if there is some correlation between the participants’ medical decision-making styles 
and follow through with treatment.  
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Understanding the Treatment Decision-making Process 
 Decisional conflict. Medical decision making related to mental health treatment appears 
to be a fairly complex process with multiple variables impacting the process. This study aimed to 
develop a greater understanding of variables which may impact decision making, including 
psychological distress, the presence of a mood disorder, income level, or educational status. 
Although the sample size was small, there were significant differences found related to some of 
these variables, particularly related to decisional conflict. Postpartum depression and anxiety can 
impact family functioning and infant development (Feldman et al., 2009). In order to support 
mothers’ psychological health, it is important to recognize these difficulties early on and 
intervene if this is what the new mother wishes. Decisional conflict or feeling confused about the 
medical treatment options can delay participation in treatment (O’Connor, 1995). The results 
from this study indicate these mothers experienced a relatively low level of decisional conflict, 
which is promising. However, results did indicate, and affirm, that high levels of decisional 
conflict impact decision making and can delay a women’s decision whether or not to seek 
treatment. This information is valuable to providers as it indicates a need to support women early 
on in the process and provide information and support on their options. If a new mother is 
experiencing depression or anxiety and delays the decision making, there may be a greater 
chance of impact on family functioning and infant development. Although these results are to be 
expected, it is notable as a delay in seeking support for depression or anxiety can have adverse 
effects on the mother’s health, infant development, and family functioning. Results from this 
study further support the need to help the decision-making process to reduce the likelihood of a 
delay in treatment decision-making (Feldman et al., 2009; O’Connor, 1995). 
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 One particularly interesting result was found related to the presence of a diagnosed mood 
disorder and decisional conflict. It should be noted this is a self-reported diagnosis and the item 
on the questionnaire simply asked participants if they had been diagnosed with a mood disorder, 
depression, or anxiety following childbirth. It was hypothesized that women who endorsed 
psychological stress would experience higher levels of decision conflict, but this was not 
supported by the results. The levels of decisional conflict were significantly lower for those 
women who self-reported a diagnosis. This finding does make sense given that in order to 
receive a diagnosis, a mother would have to have had a conversation with a healthcare provider. 
This contact, and actually receiving a diagnosis, may decrease decisional conflict around 
treatment decision making. Early detection and diagnosis is important in this process to provide a 
mother the opportunity to explore treatment options, thus, potentially decreasing decisional 
conflict. Early detection and diagnosis helps guide the decision-making process. Women who are 
working with providers, and have been diagnosed, may be given more direct information or 
support regarding their treatment options, and in turn experience lower levels of indecisiveness. 
This could be an area for further research to understand how the diagnosis may or may not 
impact the decision-making process. Previous research has suggested the presence of symptoms 
of depression may impact decision making and increase indecisiveness. Often, individuals with 
depression experience higher levels of decisional conflict and struggle with decision making in 
general, not just with medical decisions (Sit & Wisner, 2005; van Randenborgh et al., 2010). 
This result is interesting and may warrant further investigation to determine if accurate 
diagnosing, along other contributing factors, decreases conflict. The presence of general stress or 
sadness did not appear to impact decisional conflict in this sample, which is promising as well.  
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 The results are further supported by data collected on the “informed subscale” on the 
Decisional Conflict Scale. There are particular variables, including social and emotional 
variables, which may impact decisional conflict. These variables include the amount of 
information on particular courses of treatment, including information on risks and benefits. Other 
variables include personal values as well as how much support people have in making their 
decision (O’Connor, 1993). It has been suggested that less information, less clarity about values, 
and less social support may increase indecisiveness (O’Connor, 1993). Results from this study 
revealed women with a diagnosed mood disorder felt more informed about treatment options, 
and risks and benefits, than those who did not endorse a diagnosis. This is important for 
providers to understand as early detection and diagnosis may lead new mothers to gain access to 
information on treatment options and in turn, decrease decisional conflict. Furthermore, those 
women who had made a decision also felt more informed than those who had yet to decide. 
Information on diagnosis, treatment, and outcomes appears to have an impact on the process for 
new mothers. Providers can be better equipped to use screening measures to aid in detection and 
diagnosis, and feel more confident that the information they are providing about treatment 
options will impact the decision-making process. 
 In addition to feeling more informed, women who indicated they had been diagnosed 
with a mood disorder also had higher scores on the values clarity subscale. Women that had 
actually made a decision indicated that they were clearer about their personal values related to 
this healthcare decision. These results may be because women who had received a diagnosis 
have been in contact with medical or mental health providers, and as such, have had access to 
information and more of a chance to explore their personal values. However, there could be other 
factors contributing to this connection which could be examined with further research. Providers 
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can support mothers to clarify their own personal values and how they feel about outcomes to 
support their decision-making process. Results from this study revealed that a greater focus on 
these two areas may lead to a more effective decision-making process by lowering decisional 
conflict. Providers can provide high quality information on treatment options, risks and benefits, 
as well as help explore personal values with their patients to aid in the decision-making process. 
No differences were found in other areas of decisional conflict, such as perceived social support, 
levels of uncertainty, or effective decision making. Causality cannot be established regarding 
whether or not the diagnosis leads to lower conflict or if lower conflict was achieved because of 
more information and interactions with medical providers. Regardless, the results revealed there 
may be areas for providers to highlight when working with this particular population to support 
the decision-making process in the postpartum period. 
 Control in the decision-making process. Results from this study indicate new mothers 
prefer to retain some level of control in this process. There may be other healthcare decisions 
where patients prefer a more passive role and defer more control to the medical provider, such as 
cancer treatment (Degner et al., 1997). It is noteworthy that not a single respondent endorsed 
items which would defer control to the provider. Women who are experiencing symptoms in the 
postpartum period have an investment in the process. They want to be more active and have a 
shared, collaborative decision-making process with their providers. This is important information 
for providers to be aware of this as better outcomes will be achieved if they partner with their 
patients in the process, rather than take a directive approach. Other healthcare decisions may lead 
towards other trends where the patient prefers a passive role, but these results suggest patients 
want an active or collaborative role when exploring mental health treatment options. Women in 
general may desire more control over their healthcare as an informed consumer. Generally 
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speaking, it could be that women do not prefer the hierarchical model of medical decision 
making, but in turn, prefer a collaborative process in exploring treatment for their mental health 
needs. 
 Furthermore, it is important to note that psychological stress, anxiety, depression, income 
level, and education status did not impact this desire for a collaborative partnership. The majority 
of women in the sample preferred to retain control regardless of their symptoms or other 
demographic variables. This supports earlier research and further indicates the need for providers 
to understand how important the collaborative decision-making process is for seeking mental 
health treatment for postpartum depression (Patel & Wisner, 2011). 
 Provider’s role in the process. Results from the study revealed that the participants 
preferred more control in some areas of decision making and less control in other areas. Their 
involvement varied depending on the decision-making task. Overall, women preferred a 
collaborative process where both the doctor and patient share responsibility for this healthcare 
decision. However, respondents indicated they wished to retain more control on the decision-
making task. In reference to diagnosing and determining options, women opted for collaboration, 
but when asked directly who should be responsible for the actual decision, they indicated they 
wished to retain more autonomy rather than share this with their doctor. These results can help 
providers understand how their role may vary when working with new mothers around mental 
health treatment. Healthcare providers should be aware of how their role may differ depending 
on the task at hand. Women in this sample preferred an active, collaborative process overall, but 
desired even more control when making the actual decision. Healthcare providers may want to 
consider how their role varies depending on the task. For example, if they understand the 
importance of their expertise in diagnosing and proving the treatment options, they can focus 
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more energy in this area, while allowing autonomy for the actual decision. Results from this 
sample revealed women desired their provider to take a more active role for making the 
diagnosis, but may want their doctor to refrain from an active stance when actually choosing the 
treatment option. While it was hypothesized women would prefer collaborative decision making, 
results indicate that women preferred to retain a higher level of control than initially thought. 
Collaboration may be important related to the initial process of diagnosing and determining 
treatment option, but providers may need to understand women wish to have more control over 
the final decision about treatment for psychological stress in the postpartum period. 
 Treatment preferences. It was hypothesized that more women would prefer combined 
treatment options to address symptoms of psychological stress, anxiety, and depression (Patel & 
Wisner, 2011). Results from this study found that an equal number of participants opted for a 
combined treatment options and therapy only interventions. Notably, more women opted for no 
treatment over medication only interventions in this sample. It should be noted that this treatment 
preference is what the participants endorsed and may not reflect the treatment option they 
actually participated in. Further research could explore if women participated in their preferred 
treatment option and, if not, the reasons they did not participate. Literature on postpartum 
depression has revealed how complicated treatment decisions can be due to the risks and benefits 
associated with participating in treatment. Some research suggests women seeking treatment for 
psychological stress in the postpartum period are more hesitant to opt for psychopharmacological 
interventions than other populations (McCarthy & McMahon, 2008). Results from this study did 
reflect that trend, indicating women preferred either a combination of the two or opted for 
therapy only. There are many barriers to psychiatric treatment for this population, including 
accessibility of care, stigma, and risks associated with various treatment modalities (McCarthy & 
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McMahon, 2008). Given the impact on the mother, mother-infant dyad, and the potential impact 
on infant development, there are many factors to consider related to treatment options. Providers 
can be equipped with the knowledge that the majority of women prefer combined treatment 
options, including therapy and medication as indicated by this study and previous research (Patel 
& Wisner, 2011). Notably, providers should be aware of the reluctance to choose 
psychopharmacological interventions as the primary treatment modality as revealed in this study 
and research (McCarthy & McMahon, 2008; Patel & Wisner, 2011). When discussing treatment 
options, providers should be aware not only of the types of interventions, but that “no treatment” 
is also a viable option. Women in this sample indicated they preferred some type of interventions 
over no treatment, which is important information for providers. It is important to not only 
address diagnoses, but also to examine the options for intervention. Some literature indicates 
new mothers may fail to follow through on treatment options, but the process appears to be more 
complicated. The “no treatment option” is a viable option, and may not indicate a lack of follow 
through with treatment. Through understanding the decision-making process, it appears there are 
some mothers who come to the decision to decline treatment, which providers need to be made 
aware of. Given the impact of ongoing stress, anxiety, and depression on family functioning and 
infant development, providers and patients can revisit these treatment discussions if a mother 
initially declines treatment (Flynn, 2005; Paris et al., 2009).  
Conclusion 
 The research on postpartum depression has determined this is a widespread health issue 
affecting many women in the United States and around the world. Symptoms of depression and 
anxiety in the postpartum period have been shown to affect the psychological health of the 
mother, the mother-infant dyad, infant development, and family functioning (Albright, 1993). As 
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such, earlier research sought to understand the medical decision-making process for new 
mother’s in the postpartum period and their treatment preferences (Patel & Wisner, 2011). This 
study looked to explore these questions with a more diverse set of women to uncover treatment 
preferences, levels of decisional conflict, and desired role in decision making. Despite the small 
sample size, results indicated women did prefer a collaborative working relationship with their 
provider on problem solving, regardless of education status, socioeconomic status, or the 
presence of psychological stress, and preferred to retain more control to make the actual 
decision. This study supported earlier findings about women’s treatment preferences and their 
desired role in the process (Patel & Wisner, 2011). Despite limitations related to lack of ethnic 
and racial diversity, and the small sample size, this study yielded results that can help support 
this process for mothers and their families. The study revealed decision conflict can delay 
decision making and, as such, providers should be equipped to partner with the patients and 
clients to work through the process and decrease decisional conflict. Medical providers and 
mental health professionals can use this information to inform their practice when working with 
new mothers and their families. Results revealed women do prefer combined treatment options 
or therapy only treatment options, but more importantly, women may prefer no treatment over 
medication only treatment options. Medical and mental health providers interested in helping 
support treatment decision making in the postpartum period should be aware of this complex 
process to provide the highest standard of care for the people they service. 
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